Protuoso Biosciences
Develops AI-enabled multifunctional biologics platform targeting cardiometabolic, oncology, and autoimmune diseases
$9.5MSeed
Role not disclosedTV
Taya Venture
Activity from announced rounds
Activity in this selectionactive-impact-investments-cecb9648
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $9.5M 1 disclosed · full round size, not this investor’s share